Summary
The product of the growth arrest-specific gene 6 (GAS6),a ligand for tyrosine kinase receptors, is a vitamin K-dependent protein, structurally
related to anticoagulant protein S. Gas6-deficient mice are protected against thrombosis,
demonstrating the importance of this protein in the cardiovascular system. In a preliminary
study on GAS6 polymorphisms and atherothrombotic disease we found an association between the AA
genotype of the c.834+7G>A GAS6 polymorphism and stroke. In order to further explore this association by considering
GAS6 haplotypes and the main stroke subtypes,457 patients with ischemic stroke, 199 with
hemorrhagic stroke and 150 asymptomatic controls were genotyped for eight GAS6 polymorphisms and other genetic markers in the same genome region. Association was
measured by logistic regression analysis.The THESIAS program was used to measure linkage
disequilibrium and haplotype frequencies. In univariate analysis, the GAS6 c.834+7AA genotype was found associated with decreased risk for stroke (OR: 0.59;
95%CI: 0.37–0.93).After adjustment for vascular risk factors, association was maintained
when stroke subtypes affecting the microvasculature such as lacunar stroke and deep
haemorrhage, were grouped together (OR: 0.44; 95%CI: 0.21–0.90). Furthermore, haplotype
analysis revealed that association was even stronger when the c.834+7A allele was
present in a specific haplotype (CACA) of four GAS6 polymorphisms. From these results we conclude that the A allele of the GAS6 c.834+7G>A polymorphism and more specifically, the CACA haplotype, is less prevalent
in patients with stroke, suggesting a protective role for stroke of this haplotype.
Keywords
GAS6
- haplotypes - polymorphisms - stroke